Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Rapid detection of major Gram-positive pathogens in ocular specimens using a novel fluorescent vancomycin-based probe
Richa Sharmaa,
Harinee Rajagopalanb,
Maxime Klausena,
Mani Vimalin Jeyalathab,
Muhammed Üçüncüac,
Seshasailam Venkateswarana,
Appakkudal R. Anand*b and
Mark Bradley*a
aEaStCHEM, School of Chemistry, University of Edinburgh, King's Buildings, Edinburgh, EH9 3FJ, UK. E-mail: Mark.Bradley@ed.ac.uk
bL & T Microbiology Research Centre, Medical Research Foundation, Sankara Nethralaya, Chennai, India. E-mail: aranand@gmail.com
cDepartment of Analytical Chemistry, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir, Turkey
First published on 12th February 2026
Abstract
Correction for ‘Rapid detection of major Gram-positive pathogens in ocular specimens using a novel fluorescent vancomycin-based probe’ by Richa Sharma et al., Sens. Diagn., 2022, 1, 1014–1020, https://doi.org/10.1039/d2sd00061j.
The authors have added a statement in relation to the clinical specimens that was omitted in error from the published article. This statement is detailed below.
The study was approved by the Institutional Ethics committee review board of the Medical Research Foundation, Chennai, India (Ethics Approval number: 1059-2022-P). The study was conducted according to the principles expressed in the Declaration of Helsinki. All experiments involving live subjects were performed in compliance with relevant laws and followed institutional guidelines. All the clinical specimens used in this study were collected at our tertiary eye care centre (Sankara Nethralaya, Medical Research Foundation) from patients as part of routine diagnostic investigations, at the discretion of the treating physicians. Written consent was obtained from patients for the same. For the experimental studies evaluating the probe on clinical specimens, patient informed consent was waived by the Ethics committee that approves the usage of anonymized de-identified leftover patient samples collected for diagnostic purposes in accordance with our institutional and national regulations.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2026 |